Roberto Torres
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Didier Verhoeven (6 shared papers)Angelo Di Leo (6 shared papers)Guy Jérusalem (6 shared papers)Kelly Pendergrass (6 shared papers)Р. Ш. Хасанов (5 shared papers)Miguel Martín (7 shared papers)Luboš Petruželka (5 shared papers)Sally Garnett (5 shared papers)
In The Last Decade
Roberto Torres
20 papers receiving 769 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 570
- Cancer Research 280
- Pulmonary and Respiratory Medicine 532
- Genetics 302
- Genetics 23
Countries citing papers authored by Roberto Torres
This map shows the geographic impact of Roberto Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Torres more than expected).
Fields of papers citing papers by Roberto Torres
This network shows the impact of papers produced by Roberto Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Torres. The network helps show where Roberto Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2010 | 453 |
| 2 | 2013 | 232 | |
| 3 | 2013 | 17 | |
| 4 | 2012 | 17 | |
| 5 | 2009 | 16 | |
| 6 | 2016 | 11 | |
| 7 | 2018 | 9 | |
| 8 | 2010 | 9 | |
| 9 | 2021 | 7 | |
| 10 | 2006 | 4 | |
| 11 | 2025 | 3 | |
| 12 | 2012 | 3 | |
| 13 | 2015 | 3 | |
| 14 | 2009 | 3 | |
| 15 | [Laparoscopic cholecystectomy. Report of the first 1300 cases carried out by a multidisciplinary team]. | 1996 | 3 |
| 16 | 2013 | 3 | |
| 17 | Communication Methods with Limited English Proficiency Research Participants to Acquire Informed Consent During Clinical Trials | 2014 | 2 |
| 18 | 2024 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2006 | 1 |
About Roberto Torres
Roberto Torres is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Surgery and Cancer Research, having authored 20 papers that have together received 799 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Advanced Breast Cancer Therapies (9 papers), Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Computational Drug Discovery Methods (2 papers), Testicular diseases and treatments (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (570 citations), Cancer Research (280 citations), Pulmonary and Respiratory Medicine (532 citations), Genetics (302 citations) and Genetics (23 citations). Roberto Torres has collaborated with scholars based in Chile, Brazil and Italy. Frequent co-authors include Didier Verhoeven, Angelo Di Leo, Guy Jérusalem, Kelly Pendergrass, Р. Ш. Хасанов, Miguel Martín, Luboš Petruželka, Sally Garnett, Igor Bondarenko and Mikhail Lichinitser. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Frontiers in Endocrinology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.